Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T21:58:48.841Z.
Calculation as of: 2026-10-06T21:58:48.841Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5ee5b7169c987797eaa182347f1a3796ba1893154be205c45224dceb2c0886b9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-03-06.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
3.08x
EV/FCF RATIO AVG 3Y
3.08x
EV/FCF RATIO AVG 5Y
11.58x
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.89B
EV/FCF Ratio
N/A
TTM Avg
539.27x
3Y Avg
437.29x
5Y Avg
621.70x
Market Cap
$1.89B
EV/FCF Ratio
N/A
TTM Avg
34.54x
3Y Avg
34.54x
5Y Avg
34.54x
Market Cap
$1.92B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zymeworks Inc. (ZYME) | $1.89B | N/A | 3.08x | 3.08x | 11.58x |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | N/A | 539.27x | 437.29x | 621.70x |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | N/A | 34.54x | 34.54x | 34.54x |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | N/A | N/A | N/A | N/A |
| Novavax, Inc. (NVAX)vs › | $1.86B | N/A | 19.57x | 82.87x | 82.87x |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.92B | N/A | N/A | N/A | N/A |
| Immunome, Inc. (IMNM)vs › | $1.85B | N/A | 28.11x | 28.11x | 28.11x |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.94B | N/A | N/A | N/A | N/A |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | N/A | N/A | N/A | N/A |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 15.23x | 17.23x | 28.18x | 30.02x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2024-03-06 | 4.33x |
| 2024-03-05 | 4.24x |
| 2024-03-04 | 4.44x |
| 2024-03-01 | 4.44x |
| 2024-02-29 | 4.25x |
| 2024-02-28 | 4.27x |
| 2024-02-27 | 4.59x |
| 2024-02-26 | 4.39x |
| 2024-02-23 | 4.22x |
| 2024-02-22 | 4.22x |
| 2024-02-21 | 4.15x |
| 2024-02-20 | 4.26x |
| 2024-02-16 | 4.25x |
| 2024-02-15 | 4.13x |
| 2024-02-14 | 4.02x |
| 2024-02-13 | 3.97x |
| 2024-02-12 | 4.18x |
| 2024-02-09 | 3.92x |
| 2024-02-08 | 4.04x |
| 2024-02-07 | 3.99x |
| 2024-02-06 | 4.03x |
| 2024-02-05 | 3.84x |
| 2024-02-02 | 3.86x |
| 2024-02-01 | 3.85x |
| 2024-01-31 | 3.80x |
| 2024-01-30 | 3.78x |
| 2024-01-29 | 3.74x |
| 2024-01-26 | 3.63x |
| 2024-01-25 | 3.60x |
| 2024-01-24 | 3.55x |
| 2024-01-23 | 3.58x |
| 2024-01-22 | 3.50x |
| 2024-01-19 | 3.43x |
| 2024-01-18 | 3.42x |
| 2024-01-17 | 3.66x |
| 2024-01-16 | 3.68x |
| 2024-01-12 | 3.81x |
| 2024-01-11 | 3.85x |
| 2024-01-10 | 3.85x |
| 2024-01-09 | 4.05x |
| 2024-01-08 | 4.07x |
| 2024-01-05 | 3.69x |
| 2024-01-04 | 3.80x |
| 2024-01-03 | 3.73x |
| 2024-01-02 | 3.62x |
| 2023-12-29 | 3.63x |
| 2023-12-28 | 3.75x |
| 2023-12-27 | 3.76x |
| 2023-12-26 | 3.74x |
| 2023-12-22 | 3.41x |
| 2023-12-21 | 3.21x |
| 2023-12-20 | 3.20x |
| 2023-12-19 | 3.22x |
| 2023-12-18 | 3.11x |
| 2023-12-15 | 3.13x |
| 2023-12-14 | 3.10x |
| 2023-12-13 | 3.19x |
| 2023-12-12 | 3.16x |
| 2023-12-11 | 3.18x |
| 2023-12-08 | 3.20x |
| 2023-12-07 | 3.30x |
| 2023-12-06 | 3.13x |
| 2023-12-05 | 3.10x |
| 2023-12-04 | 3.18x |
| 2023-12-01 | 3.15x |
| 2023-11-30 | 3.04x |
| 2023-11-29 | 3.02x |
| 2023-11-28 | 2.99x |
| 2023-11-27 | 2.90x |
| 2023-11-24 | 2.76x |
| 2023-11-22 | 2.84x |
| 2023-11-21 | 2.79x |
| 2023-11-20 | 2.85x |
| 2023-11-17 | 2.78x |
| 2023-11-16 | 2.62x |
| 2023-11-15 | 2.60x |
| 2023-11-14 | 2.56x |
| 2023-11-13 | 2.43x |
| 2023-11-10 | 2.43x |
| 2023-11-09 | 2.30x |
| 2023-11-08 | 2.36x |
| 2023-11-07 | 2.53x |
| 2023-11-06 | 2.49x |
| 2023-11-03 | 2.56x |
| 2023-11-02 | 2.39x |
| 2023-11-01 | 2.38x |
| 2023-10-31 | 2.38x |
| 2023-10-30 | 2.36x |
| 2023-10-27 | 2.21x |
| 2023-10-26 | 2.22x |
| 2023-10-25 | 2.35x |
| 2023-10-24 | 2.37x |
| 2023-10-23 | 2.37x |
| 2023-10-20 | 2.45x |
| 2023-10-19 | 2.46x |
| 2023-10-18 | 2.44x |
| 2023-10-17 | 2.48x |
| 2023-10-16 | 2.39x |
| 2023-10-13 | 2.14x |
| 2023-10-12 | 2.11x |
| 2023-10-11 | 2.14x |
| 2023-10-10 | 2.12x |
| 2023-10-09 | 2.05x |
| 2023-10-06 | 2.10x |
| 2023-10-05 | 2.04x |
| 2023-10-04 | 2.02x |
| 2023-10-03 | 2.00x |
| 2023-10-02 | 2.00x |
| 2023-09-29 | 2.07x |
| 2023-09-28 | 2.03x |
| 2023-09-27 | 2.02x |
| 2023-09-26 | 2.09x |
| 2023-09-25 | 2.09x |
| 2023-09-22 | 2.10x |
| 2023-09-21 | 2.13x |
| 2023-09-20 | 2.21x |
| 2023-09-19 | 2.32x |
| 2023-09-18 | 2.27x |
| 2023-09-15 | 2.28x |
| 2023-09-14 | 2.27x |
| 2023-09-13 | 2.30x |
| 2023-09-12 | 2.31x |
| 2023-09-11 | 2.37x |
| 2023-09-08 | 2.42x |
| 2023-09-07 | 2.35x |
| 2023-09-06 | 2.46x |
| 2023-09-05 | 2.51x |
| 2023-09-01 | 2.59x |
| 2023-08-31 | 2.47x |
| 2023-08-30 | 2.52x |
| 2023-08-29 | 2.60x |
| 2023-08-28 | 2.59x |
| 2023-08-25 | 2.68x |
| 2023-08-24 | 2.66x |
| 2023-08-23 | 2.80x |
| 2023-08-22 | 2.75x |
| 2023-08-21 | 2.66x |
| 2023-08-18 | 2.55x |
| 2023-08-17 | 2.52x |
| 2023-08-16 | 2.49x |
| 2023-08-15 | 2.55x |
| 2023-08-14 | 2.59x |
| 2023-08-11 | 2.44x |
| 2023-08-10 | 3.67x |
| 2023-08-09 | 3.63x |
| 2023-08-08 | 3.35x |
| 2023-08-07 | 3.33x |
| 2023-08-04 | 3.42x |
| 2023-08-03 | 3.37x |
| 2023-08-02 | 3.37x |
| 2023-08-01 | 3.46x |
| 2023-07-31 | 3.47x |
| 2023-07-28 | 3.34x |
| 2023-07-27 | 3.35x |
| 2023-07-26 | 3.50x |
| 2023-07-25 | 3.46x |
| 2023-07-24 | 3.42x |
| 2023-07-21 | 3.74x |
| 2023-07-20 | 3.68x |
| 2023-07-19 | 3.74x |
| 2023-07-18 | 3.74x |
| 2023-07-17 | 3.81x |
| 2023-07-14 | 3.76x |
| 2023-07-13 | 4.04x |
| 2023-07-12 | 4.07x |
| 2023-07-11 | 3.84x |
| 2023-07-10 | 3.96x |
| 2023-07-07 | 4.01x |
| 2023-07-06 | 3.95x |
| 2023-07-05 | 4.22x |
| 2023-07-03 | 4.22x |
| 2023-06-30 | 4.26x |
| 2023-06-29 | 4.20x |
| 2023-06-28 | 4.23x |
| 2023-06-27 | 3.95x |
| 2023-06-26 | 3.76x |
| 2023-06-23 | 3.91x |
| 2023-06-22 | 4.06x |
| 2023-06-21 | 3.95x |
| 2023-06-20 | 4.09x |
| 2023-06-16 | 3.91x |
| 2023-06-15 | 3.95x |
| 2023-06-14 | 4.05x |
| 2023-06-13 | 4.24x |
| 2023-06-12 | 4.07x |
| 2023-06-09 | 4.18x |
| 2023-06-08 | 4.32x |
| 2023-06-07 | 4.43x |
| 2023-06-06 | 4.38x |
| 2023-06-05 | 4.46x |
| 2023-06-02 | 4.28x |
| 2023-06-01 | 4.16x |
| 2023-05-31 | 3.99x |
| 2023-05-30 | 3.95x |
| 2023-05-26 | 4.00x |
| 2023-05-25 | 4.11x |
| 2023-05-24 | 4.37x |
| 2023-05-23 | 4.65x |
| 2023-05-22 | 4.63x |
| 2023-05-19 | 5.02x |
| 2023-05-18 | 4.90x |
| 2023-05-17 | 4.63x |
| 2023-05-16 | 4.53x |
| 2023-05-15 | 5.06x |
| 2023-05-12 | 5.08x |
| 2023-05-11 | 5.17x |
| 2023-05-10 | 4.97x |
| 2023-05-09 | 5.10x |
| 2023-05-08 | 1.72x |
| 2023-05-05 | 1.65x |
| 2023-05-04 | 1.57x |
| 2023-05-03 | 1.55x |
| 2023-05-02 | 1.41x |
| 2023-05-01 | 1.54x |
| 2023-04-28 | 1.52x |
| 2023-04-27 | 1.56x |
| 2023-04-26 | 1.71x |
| 2023-04-25 | 1.88x |
| 2023-04-24 | 2.26x |
| 2023-04-21 | 2.30x |
| 2023-04-20 | 2.30x |
| 2023-04-19 | 2.33x |
| 2023-04-18 | 2.38x |
| 2023-04-17 | 2.51x |
| 2023-04-14 | 2.35x |
| 2023-04-13 | 2.43x |
| 2023-04-12 | 2.07x |
| 2023-04-11 | 1.85x |
| 2023-04-10 | 2.05x |
| 2023-04-06 | 2.06x |
| 2023-04-05 | 2.07x |
| 2023-04-04 | 2.06x |
| 2023-04-03 | 2.05x |
| 2023-03-31 | 1.87x |
| 2023-03-30 | 1.72x |
| 2023-03-29 | 1.65x |
| 2023-03-28 | 1.34x |
| 2023-03-27 | 1.36x |
| 2023-03-24 | 1.41x |
| 2023-03-23 | 1.41x |
| 2023-03-22 | 1.51x |
| 2023-03-21 | 1.80x |
| 2023-03-20 | 1.59x |
| 2023-03-17 | 1.50x |
| 2023-03-16 | 1.47x |
| 2023-03-15 | 1.65x |
| 2023-03-14 | 1.56x |
| 2023-03-13 | 1.44x |
| 2023-03-10 | 1.27x |
| 2023-03-09 | 1.35x |
| 2023-03-08 | 1.30x |
| 2019-08-02 | 41.62x |
| 2019-08-01 | 41.64x |
| 2019-07-31 | 40.59x |
| 2019-07-30 | 41.23x |
| 2019-07-29 | 43.04x |
| 2019-07-26 | 43.17x |
| 2019-07-25 | 43.21x |
| 2019-07-24 | 43.30x |
| 2019-07-23 | 43.32x |
Showing the most recent 260 of 503 data points. The chart above shows the full history.
